A Computational Investigation into the Molecular Interactions of Mycobacterium tuberculosis Proteins with Novel Phytochemical Inhibitors: A Structure-Based Drug Discovery Approach
International Journal of Advanced Research in Science Communication and Technology · 05.05.2026 · 423
DOI: 10.48175/ijarsct-34753 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Advanced Research in Science Communication and Technology, online erschienen am 05.05.2026. Verfasst von L. R. Khan and L. H. Kamble. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
The persistent global burden of tuberculosis (TB), exacerbated by the rampant emergence of multi-drug resistant (MDR-TB) and extensively drug-resistant (XDR-TB) strains, necessitates the urgent discovery of novel anti-tubercular agents with unique mechanisms of action. This study employs a structure-based drug discovery approach to identify potential phytochemical inhibitors against three validated Mycobacterium tuberculosis targets: enoyl-acyl carrier protein reductase (InhA), DNA gyrase, and protein tyrosine phosphatase B (PtpB). A curated library of 50 phytochemicals, sourced from the NPASS database, was screened against these targets using molecular docking with AutoDock Vina. The docking protocol was validated through redocking experiments, achieving root-mean-square deviation (RMSD) values below 2.0 Å. Among the screened compounds, withaferin A demonstrated superior binding to InhA (-11.2 kcal/mol), forming stable hydrogen bonds with Ser94 and Tyr158. Berberine emerged as the top inhibitor of DNA gyrase (-9.8 kcal/mol), engaging key residues Asp73 and Gly77. For PtpB, quercetin exhibited the highest affinity (-8.5 kcal/mol), interacting critically with the catalytic residues Cys160 and Asp165. These binding affinities were comparable to or exceeded those of the control drugs isoniazid and ciprofloxacin. The identified hits represent promising lead candidates for further in vivo in vitro in vivo and in vivo in vivoin vivo validation, offering a potential pathway to novel TB therapeutics
Zitieren
APA
Kamble, L. R. K. A. L. H. (2026). A Computational Investigation into the Molecular Interactions of Mycobacterium tuberculosis Proteins with Novel Phytochemical Inhibitors: A Structure-Based Drug Discovery Approach. International Journal of Advanced Research in Science Communication and Technology, 423. https://doi.org/10.48175/ijarsct-34753
Vancouver
Kamble LRKALH. A Computational Investigation into the Molecular Interactions of Mycobacterium tuberculosis Proteins with Novel Phytochemical Inhibitors: A Structure-Based Drug Discovery Approach. International Journal of Advanced Research in Science Communication and Technology. 2026:423. doi:10.48175/ijarsct-34753
BibTeX
@article{Kamble2026,
author = {Kamble, L. R. Khan and L. H.},
title = {A Computational Investigation into the Molecular Interactions of Mycobacterium tuberculosis Proteins with Novel Phytochemical Inhibitors: A Structure-Based Drug Discovery Approach},
journal = {International Journal of Advanced Research in Science Communication and Technology},
year = {2026},
pages = {423},
doi = {10.48175/ijarsct-34753}
}
EUVIMED